Evaluating the Long-Term Cost-Effectiveness of Liraglutide Versus Exenatide BID in Patients With Type 2 Diabetes Who Fail to Improve With Oral Antidiabetic Agents
- Resource Type
- Article
- Source
- In
Clinical Therapeutics 2011 33(11):1698-1712 - Subject
- Language
- ISSN
- 0149-2918